Clinical Trial Update: Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infants [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy, safety, reactogenicity, and immunogenicity of the Rotarix vaccine in Japanese infants has completed, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infection
• Rotavirus Vaccination

Drugs mentioned

• Rotarix (Rotavirus vaccine (live attenuated))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Rotavirus, Rotavirus Vaccines | Phase 3 | Status: COMPLETED | Results posted: 2010-11-17